BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/26/2025 7:27:59 AM | Browse: 3 | Download: 30
 |
Received |
|
2025-02-27 11:53 |
|
Peer-Review Started |
|
2025-03-10 00:44 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-04-01 12:54 |
|
Revised |
|
2025-04-15 09:44 |
|
Second Decision |
|
2025-06-03 02:55 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-06-03 10:17 |
|
Articles in Press |
|
2025-06-03 10:17 |
|
Publication Fee Transferred |
|
2025-04-21 04:16 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-06-16 08:00 |
|
Publish the Manuscript Online |
|
2025-06-26 07:27 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Human albumin infusion for reducing hyponatremia and circulatory dysfunction in liver cirrhosis: A meta-analysis update
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Hui-Juan Zhou, Zi-Qiang Li, Da-Er Dili and Qing Xie |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
82070604 |
| the Shanghai Municipal Key Clinical Specialty, China |
shslczdzk01103 |
| National Natural Science Foundation of China |
82270618 |
|
| Corresponding Author |
Qing Xie, Chief Physician, Full Professor, PhD, Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197 Ruijin Second Road, Shanghai (Yongjia Intersection), Shanghai 200025, China. xieqingrjh@163.com |
| Key Words |
Albumin; Efficacy; Hepatic encephalopathy; Hyponatremia; Liver cirrhosis; Mortality; Paracentesis-induced circulatory dysfunction; Safety |
| Core Tip |
Liver cirrhosis is one of the leading causes of death worldwide, which imposes a substantial public health burden. The efficacy of various therapies, such as albumin infusion, volume expanders (VEs), and vasoactive drugs, used to treat patients with cirrhosis is still not clear. This meta-analysis compares albumin infusion, VEs, and vasoactive agents for the treatment of liver cirrhosis. Albumin infusion significantly decreases hyponatremia and paracentesis induced circulatory dysfunction compared to other treatments. These findings indicate that albumin therapy is more effective against complications of liver cirrhosis compared to other treatments. |
| Publish Date |
2025-06-26 07:27 |
| Citation |
<p>Zhou HJ, Li ZQ, Dili DE, Xie Q. Human albumin infusion for reducing hyponatremia and circulatory dysfunction in liver cirrhosis: A meta-analysis update. <i>World J Hepatol</i> 2025; 17(6): 106418</p> |
| URL |
https://www.wjgnet.com/1948-5182/full/v17/i6/106418.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v17.i6.106418 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
